LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Photo from wikipedia

Rolf Gedeborg, Hans Garmo , Camilla Thellenberg-Karlsson , Giuseppe Fallara , Johan Styrke, Ingela Franck Lissbrant and P€ar Stattin Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Translational Oncology and… Click to show full abstract

Rolf Gedeborg, Hans Garmo , Camilla Thellenberg-Karlsson , Giuseppe Fallara , Johan Styrke, Ingela Franck Lissbrant and P€ar Stattin Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Translational Oncology and Urology Research (TOUR), King’s College London, Guy’s Hospital, London, UK; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden; Division of Experimental Oncology, Unit of Urology URI, IRCCS Ospedale San Raffaele, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden; Department of Oncology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Keywords: department; treatment abiraterone; urology; oncology; time treatment; university

Journal Title: Acta Oncologica
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.